This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08261/identifier/pubchem-substance/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08261/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08261/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB08261/identifier/pubchem-compound/

Statements

Subject Item
n2:DB08261
rdf:type
n4:Drug
n4:description
2-hydroxy-7-methoxy-5-methyl-naphthalene-1-carboxylic acid meso-2,5-dihydroxy-cyclopent-3-enyl ester is a solid. This compound belongs to the naphthalenecarboxylic acids and derivatives. These are compounds containing a napthalene moiety with a ring carbon which bears a carboxylic acid group or a derivative. This drug targets the protein neocarzinostatin.
n4:group
experimental
owl:sameAs
n12:DB08261 n13:DB08261
dcterms:title
2-hydroxy-7-methoxy-5-methyl-naphthalene-1-carboxylic acid meso-2,5-dihydroxy-cyclopent-3-enyl ester
adms:identifier
n7:NCZ n8:446415 n9:DB08261 n10:99444732
n4:IUPAC-Name
n5:271B46F7-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B46FD-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B46FC-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B46F9-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B46FA-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B46FB-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B46F5-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B46F3-363D-11E5-9242-09173F13E4C5 n5:271B46F6-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B46F4-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B4703-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B4704-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B46FE-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B46FF-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B4701-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B4700-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B4702-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B4709-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B470B-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B470C-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B4708-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B4707-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B470A-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B46F8-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B4705-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B4706-363D-11E5-9242-09173F13E4C5